Quick answer
Medicines Discovery Catapult Open Calls is a UK funding programme. UK SMEs in drug discovery seeking access to capabilities, data, and collaboration. Funding: Programme-dependent. Drug-discovery SMEs needing collaboration and capability access. It is published as a standard listing — verify current rounds and full criteria on the official source before applying.
Advisor summary
Medicines Discovery Catapult Open Calls is a grant. Medicines Discovery Catapult Open Calls. UK SMEs in drug discovery seeking access to capabilities, data, and collaboration. Based on the published criteria, Medicines Discovery Catapult Open Calls is most relevant to startup businesses; organisations working in Life Sciences; applicants based in United Kingdom. It typically supports activities aligned with Innovation & R&D — applications that demonstrate a clear, evidenced link to one of these objectives tend to score better against the published assessment framework. Eligibility focus: UK SMEs in drug discovery seeking access to capabilities, data, and collaboration. Medicines Discovery Catapult Open Calls is most useful when you need non-repayable funding for a defined project with clear outputs. If your situation does not match that profile, the Alternative Routes section below lists more suitable options before you commit time to an application. Before applying, confirm the scheme is currently open on the official source page — funding amounts, deadlines and round-by-round priorities for Medicines Discovery Catapult Open Calls can change between calls.
Key takeaways
- Funding type: grant.
- Target stage: startup.
- Geographic coverage: United Kingdom.
- Aligned to objectives such as Innovation & R&D.
- Industry relevance: Life Sciences.
- Always validate live eligibility and timing on the official source before applying.
Who this is for
Medicines Discovery Catapult Open Calls is most relevant to: - startup businesses that match the published stage definition - organisations operating in Life Sciences - applicants based in United Kingdom - teams whose planned activity advances Innovation & R&D - organisations that can evidence eligibility, deliverability and value-for-money against the scheme's published criteria Use the eligibility section above to validate fit before applying.
Real-world use cases
- Innovation & R&D projects seeking grant support consistent with the published scope of Medicines Discovery Catapult Open Calls.
- Life Sciences businesses where the planned activity matches the eligible activity list and can be delivered within the scheme's reporting window.
- Projects delivered in United Kingdom where the applicant is registered and trading in the eligible geography.
- Projects whose planned activities, costs and outputs map cleanly onto the assessment criteria published for Medicines Discovery Catapult Open Calls.
What to prepare
- Read the official guidance end-to-end and note every mandatory criterion.
- Confirm the current round is open and check the live deadline on the official source.
- Pull recent management accounts and statutory financials covering the requested period.
- Draft a clear project description: problem, approach, milestones, outputs.
- Prepare a defensible budget that ties each cost line to a project milestone.
- Identify and brief any partners, suppliers or supporting referees in advance.
- Leave time for internal review and sign-off before submission.
- Capture the assumptions behind any quantitative claims (jobs created, emissions saved, additional R&D spend) so they can be defended at assessment.
Common mistakes
- Treating the application as a marketing exercise rather than evidencing eligibility against the published criteria.
- Submitting without independently verifying the live deadline and current call status on the official source page.
- Underestimating the time required to gather match-funding evidence and supporting letters.
- Vague project descriptions that fail to spell out outputs, milestones and a credible delivery plan.
- Weak budget breakdowns that mix capital and revenue costs without justification.
- Failing to make the connection to Innovation & R&D explicit — assessors should not have to infer how Medicines Discovery Catapult Open Calls fits the project.
Why applications get rejected
- Project falls outside the published scope, theme or eligible activities.
- Applicant organisation type or location is not eligible under the call.
- Insufficient evidence of match funding or co-investment where required.
- Project plan, milestones or budget lack the detail assessors need to score against the criteria.
- Limited evidence of impact, additionality or value for money.
- Applicant or project location does not satisfy the geographic eligibility for Medicines Discovery Catapult Open Calls (United Kingdom).
Alternative funding routes
- Consider related grant routes such as Kent and Medway Growth Hub, Tees Valley Investment Zone Business Support, Innovate UK Innovation Loans — see the Related grants section for direct links.
- Use side-by-side comparisons such as Innovate UK Innovation Loans vs R&D Tax Relief and Innovate UK Smart Grants vs Innovate UK Innovation Loans to weigh Medicines Discovery Catapult Open Calls against the closest alternatives before committing.
- The decision guides Should I claim R&D Tax Relief or apply for a grant? and When should a company move from grants to investment? walk through the trade-offs in plain English.
- Schemes targeting Innovation & R&D from other providers may offer complementary or fallback coverage if Medicines Discovery Catapult Open Calls is not a fit this round.
- If grant funding is not a fit, debt or equity routes may be appropriate — review the Pathways section for a structured comparison.
Typical funding journey
- 1Discovery — confirm the scheme is open and you fit the published scope.
- 2Eligibility check — work through the criteria honestly and gather evidence of fit.
- 3Scoping — define the project, outputs, milestones and a defensible budget.
- 4Documentation — assemble financials, letters of support and any required quotes.
- 5Submission — complete the official application form against the assessor criteria.
- 6Assessment — respond promptly to clarification requests during review.
- 7Decision and grant agreement — accept the offer and meet pre-payment conditions.
Frequently asked questions
Who is eligible to apply for Medicines Discovery Catapult Open Calls?
Medicines Discovery Catapult Open Calls is aimed at early-stage startups. It is available to applicants in United Kingdom. Industry focus areas include Life Sciences. Always confirm the live eligibility criteria on the official source page before applying — eligibility rules can change between rounds.
What does Medicines Discovery Catapult Open Calls fund?
As a grant scheme, Medicines Discovery Catapult Open Calls typically supports activities consistent with its published objectives (Innovation & R&D). Specific eligible costs and project types are defined in the scheme's published guidance — review the official source page for the current list.
How competitive is Medicines Discovery Catapult Open Calls?
Published competitiveness figures vary by round and are not always disclosed. Treat any scheme with limited published cost as competitive: prepare as if you were one of many strong applicants, and lean on the assessment criteria when building your application.
What preparation is needed before applying to Medicines Discovery Catapult Open Calls?
Start by reading the official guidance end-to-end and mapping your project against each assessment criterion. Pull together core supporting evidence early — typically organisation details, recent financials, a clear project description, milestones and a budget. Leave time for internal review and, where relevant, partner or advisor sign-off before submission.
What documents are usually required for Medicines Discovery Catapult Open Calls?
Most schemes ask for organisation details, recent financial information, a project description with milestones, and a budget breakdown. Always check the official source page for the definitive document list for the current round.
What alternatives exist if Medicines Discovery Catapult Open Calls is not a fit?
The Alternative Routes section above lists related funding paths. As a general rule, look for schemes targeting the same objective or stage from different providers, and consider blending sources (for example combining a grant with a loan or equity) where the project size warrants it.
How do you apply for Medicines Discovery Catapult Open Calls?
Application routing is set out on the official source page linked above — confirm the current round is open before starting an application.
When should you start preparing for Medicines Discovery Catapult Open Calls?
Treat preparation as a multi-week process for most schemes. Begin gathering financials, project documentation and supporting evidence as soon as you decide to apply — leaving preparation to the final week typically shows in the quality of the application.
What happens after you apply to Medicines Discovery Catapult Open Calls?
Applications are typically logged, screened for eligibility, then assessed against the published criteria. Be ready to respond quickly to clarification requests during review, and keep contact details up to date so decision notifications are not missed.
Can Medicines Discovery Catapult Open Calls be combined with other funding or support?
Many public grants impose subsidy-control limits and require disclosure of other public support received in the past three years. Read the scheme's published rules on combined funding before committing — the answer changes case-by-case.
What should applicants do before applying to Medicines Discovery Catapult Open Calls?
Validate that Medicines Discovery Catapult Open Calls is genuinely the best fit — the Alternative Routes section above lists other options worth comparing first. Re-read the official guidance and map your project, organisation and budget to each scoring criterion. Walk through the Eligibility section line by line and gather evidence for every requirement. Speak to anyone in your network who has been through this scheme recently — round-by-round priorities and assessor focus shift.
What makes a strong application to Medicines Discovery Catapult Open Calls?
Strong Medicines Discovery Catapult Open Calls applications evidence fit against every published criterion rather than restating the project's ambition. Use concrete numbers, dated milestones and named partners wherever possible — assessors reward specificity. Make the link to Innovation & R&D explicit; do not leave assessors to infer it. Show that the project would not happen — or would happen later or smaller — without this funding (the 'additionality' test).
When might another funding route be more suitable than Medicines Discovery Catapult Open Calls?
If your project needs flexible working capital, fast decisions, or covers costs outside the published scope, a loan or equity route is usually a better fit. See the Alternative Routes section above for specific suggestions.
What happens after Medicines Discovery Catapult Open Calls is awarded?
Funded organisations typically sign a grant or facility agreement that sets out drawdown conditions, reporting cadence and any claw-back triggers. Plan for periodic progress reports, evidence of spend and — for larger awards — independent monitoring or audit. Most public funders require you to retain underlying records for several years in case of audit.
How should organisations prepare supporting evidence for Medicines Discovery Catapult Open Calls?
Gather evidence in the order assessors will read it: organisation legitimacy first, then eligibility, then project fit, then budget and impact. Even where a document list is not published, prepare financials, a project plan with milestones, and budget evidence as a baseline. Where claims are quantitative (job creation, emissions reduction, additional R&D spend), document the assumption behind each number.
Read end-to-end by a FundingAtlas editor against the official source.
Funding amount
Programme-dependent
Region
United Kingdom
Stage
Startup
Provider
Medicines Discovery Catapult
Advisor summary
Medicines Discovery Catapult Open Calls is a grant. Medicines Discovery Catapult Open Calls. UK SMEs in drug discovery seeking access to capabilities, data, and collaboration. Based on the published criteria, Medicines Discovery Catapult Open Calls is most relevant to startup businesses; organisations working in Life Sciences; applicants based in United Kingdom. It typically supports activities aligned with Innovation & R&D — applications that demonstrate a clear, evidenced link to one of these objectives tend to score better against the published assessment framework. Eligibility focus: UK SMEs in drug discovery seeking access to capabilities, data, and collaboration. Medicines Discovery Catapult Open Calls is most useful when you need non-repayable funding for a defined project with clear outputs. If your situation does not match that profile, the Alternative Routes section below lists more suitable options before you commit time to an application. Before applying, confirm the scheme is currently open on the official source page — funding amounts, deadlines and round-by-round priorities for Medicines Discovery Catapult Open Calls can change between calls.
Key takeaways
- Funding type: grant.
- Target stage: startup.
- Geographic coverage: United Kingdom.
- Aligned to objectives such as Innovation & R&D.
- Industry relevance: Life Sciences.
- Always validate live eligibility and timing on the official source before applying.
Who this is for
Medicines Discovery Catapult Open Calls is most relevant to: - startup businesses that match the published stage definition - organisations operating in Life Sciences - applicants based in United Kingdom - teams whose planned activity advances Innovation & R&D - organisations that can evidence eligibility, deliverability and value-for-money against the scheme's published criteria Use the eligibility section above to validate fit before applying.
What to prepare before applying
- 1
Read the official guidance end-to-end and note every mandatory criterion.
- 2
Confirm the current round is open and check the live deadline on the official source.
- 3
Pull recent management accounts and statutory financials covering the requested period.
- 4
Draft a clear project description: problem, approach, milestones, outputs.
- 5
Prepare a defensible budget that ties each cost line to a project milestone.
- 6
Identify and brief any partners, suppliers or supporting referees in advance.
- 7
Leave time for internal review and sign-off before submission.
- 8
Capture the assumptions behind any quantitative claims (jobs created, emissions saved, additional R&D spend) so they can be defended at assessment.
Common mistakes
Treating the application as a marketing exercise rather than evidencing eligibility against the published criteria.
Submitting without independently verifying the live deadline and current call status on the official source page.
Underestimating the time required to gather match-funding evidence and supporting letters.
Vague project descriptions that fail to spell out outputs, milestones and a credible delivery plan.
Weak budget breakdowns that mix capital and revenue costs without justification.
Failing to make the connection to Innovation & R&D explicit — assessors should not have to infer how Medicines Discovery Catapult Open Calls fits the project.
Common rejection reasons
Project falls outside the published scope, theme or eligible activities.
Applicant organisation type or location is not eligible under the call.
Insufficient evidence of match funding or co-investment where required.
Project plan, milestones or budget lack the detail assessors need to score against the criteria.
Limited evidence of impact, additionality or value for money.
Applicant or project location does not satisfy the geographic eligibility for Medicines Discovery Catapult Open Calls (United Kingdom).
Alternative funding routes
Consider related grant routes such as Kent and Medway Growth Hub, Tees Valley Investment Zone Business Support, Innovate UK Innovation Loans — see the Related grants section for direct links.
Use side-by-side comparisons such as Innovate UK Innovation Loans vs R&D Tax Relief and Innovate UK Smart Grants vs Innovate UK Innovation Loans to weigh Medicines Discovery Catapult Open Calls against the closest alternatives before committing.
The decision guides Should I claim R&D Tax Relief or apply for a grant? and When should a company move from grants to investment? walk through the trade-offs in plain English.
Schemes targeting Innovation & R&D from other providers may offer complementary or fallback coverage if Medicines Discovery Catapult Open Calls is not a fit this round.
If grant funding is not a fit, debt or equity routes may be appropriate — review the Pathways section for a structured comparison.
Usually too early when
Advisor signal
Apply before you can clearly articulate the project scope, evidence of fit with Medicines Discovery Catapult's priorities, and a credible delivery plan. Businesses earlier than the startup stage typically struggle to evidence the operational thresholds assessors look for.
Eligibility
UK SMEs in drug discovery seeking access to capabilities, data, and collaboration.
Common reasons applications fail
Reasons applications fail or stall: • Weak fit with the stated objectives of the scheme. • Vague impact claims without named metrics, baselines or timing. • Match funding not secured at the point of application. • Project plan that reads like business-as-usual rather than additional, new activity. • Insufficient evidence the team has delivered comparable work before. • Late engagement — applying close to deadline without internal sign-off.
What improves your odds
Strong alignment with Medicines Discovery Catapult's published priorities. A specific, measurable project with named deliverables and timelines. Evidence the team can deliver — relevant prior projects, named technical leads, and secured (not hoped-for) match funding where required. Clear quantified impact: jobs, productivity, exports, emissions reduction or commercial outcomes appropriate to the scheme.
Typical successful applicant
A UK-based organisation that already meets the eligibility criteria for Medicines Discovery Catapult Open Calls on paper, has prior delivery experience relevant to Medicines Discovery Catapult, and can evidence the stated impact within the funding window.
Common misconceptions
That Medicines Discovery Catapult Open Calls is a quick or guaranteed source of capital. It is not — assessment is competitive and most applicants are unsuccessful. That a strong application can be drafted in days; in practice, competitive submissions take weeks of preparation, evidence gathering, and internal sign-off.
What comes next
On a successful award: deliver against the agreed milestones, build the evidence base for follow-on funding (commercial pilots, larger grants, debt or equity), and document outcomes that strengthen the next application. On rejection: request feedback, address the specific weaknesses, and consider an adjacent scheme on the Innovation Funding Pathway before re-applying.
Funding context
Medicines Discovery Catapult Open Calls sits within Medicines Discovery Catapult's wider funding remit. Treat it as one option on the Innovation Funding Pathway; the right route depends on stage, project type and what comes next commercially. Use it alongside, not instead of, complementary support.
Eligibility Quick Check
A cautious, rules-based check using only the criteria already published for this programme. Not a guarantee — always verify against the official source.
Frequently asked questions
- Who is eligible to apply for Medicines Discovery Catapult Open Calls?
- Medicines Discovery Catapult Open Calls is aimed at early-stage startups. It is available to applicants in United Kingdom. Industry focus areas include Life Sciences. Always confirm the live eligibility criteria on the official source page before applying — eligibility rules can change between rounds.
- What does Medicines Discovery Catapult Open Calls fund?
- As a grant scheme, Medicines Discovery Catapult Open Calls typically supports activities consistent with its published objectives (Innovation & R&D). Specific eligible costs and project types are defined in the scheme's published guidance — review the official source page for the current list.
- How competitive is Medicines Discovery Catapult Open Calls?
- Published competitiveness figures vary by round and are not always disclosed. Treat any scheme with limited published cost as competitive: prepare as if you were one of many strong applicants, and lean on the assessment criteria when building your application.
- What preparation is needed before applying to Medicines Discovery Catapult Open Calls?
- Start by reading the official guidance end-to-end and mapping your project against each assessment criterion. Pull together core supporting evidence early — typically organisation details, recent financials, a clear project description, milestones and a budget. Leave time for internal review and, where relevant, partner or advisor sign-off before submission.
- What documents are usually required for Medicines Discovery Catapult Open Calls?
- Most schemes ask for organisation details, recent financial information, a project description with milestones, and a budget breakdown. Always check the official source page for the definitive document list for the current round.
- What alternatives exist if Medicines Discovery Catapult Open Calls is not a fit?
- The Alternative Routes section above lists related funding paths. As a general rule, look for schemes targeting the same objective or stage from different providers, and consider blending sources (for example combining a grant with a loan or equity) where the project size warrants it.
- How do you apply for Medicines Discovery Catapult Open Calls?
- Application routing is set out on the official source page linked above — confirm the current round is open before starting an application.
- When should you start preparing for Medicines Discovery Catapult Open Calls?
- Treat preparation as a multi-week process for most schemes. Begin gathering financials, project documentation and supporting evidence as soon as you decide to apply — leaving preparation to the final week typically shows in the quality of the application.
- What happens after you apply to Medicines Discovery Catapult Open Calls?
- Applications are typically logged, screened for eligibility, then assessed against the published criteria. Be ready to respond quickly to clarification requests during review, and keep contact details up to date so decision notifications are not missed.
- Can Medicines Discovery Catapult Open Calls be combined with other funding or support?
- Many public grants impose subsidy-control limits and require disclosure of other public support received in the past three years. Read the scheme's published rules on combined funding before committing — the answer changes case-by-case.
- What should applicants do before applying to Medicines Discovery Catapult Open Calls?
- Validate that Medicines Discovery Catapult Open Calls is genuinely the best fit — the Alternative Routes section above lists other options worth comparing first. Re-read the official guidance and map your project, organisation and budget to each scoring criterion. Walk through the Eligibility section line by line and gather evidence for every requirement. Speak to anyone in your network who has been through this scheme recently — round-by-round priorities and assessor focus shift.
- What makes a strong application to Medicines Discovery Catapult Open Calls?
- Strong Medicines Discovery Catapult Open Calls applications evidence fit against every published criterion rather than restating the project's ambition. Use concrete numbers, dated milestones and named partners wherever possible — assessors reward specificity. Make the link to Innovation & R&D explicit; do not leave assessors to infer it. Show that the project would not happen — or would happen later or smaller — without this funding (the 'additionality' test).
- When might another funding route be more suitable than Medicines Discovery Catapult Open Calls?
- If your project needs flexible working capital, fast decisions, or covers costs outside the published scope, a loan or equity route is usually a better fit. See the Alternative Routes section above for specific suggestions.
- What happens after Medicines Discovery Catapult Open Calls is awarded?
- Funded organisations typically sign a grant or facility agreement that sets out drawdown conditions, reporting cadence and any claw-back triggers. Plan for periodic progress reports, evidence of spend and — for larger awards — independent monitoring or audit. Most public funders require you to retain underlying records for several years in case of audit.
- How should organisations prepare supporting evidence for Medicines Discovery Catapult Open Calls?
- Gather evidence in the order assessors will read it: organisation legitimacy first, then eligibility, then project fit, then budget and impact. Even where a document list is not published, prepare financials, a project plan with milestones, and budget evidence as a baseline. Where claims are quantitative (job creation, emissions reduction, additional R&D spend), document the assumption behind each number.
Related routes
Industries
Objectives
Regions